UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 26, 2014 (September 26, 2014)
VIVEVE MEDICAL, INC.
(Exact name of registrant as specified in its charter)
Yukon Territory, Canada | 1-11388 | 04-3153858 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
150 Commercial Street Sunnyvale, California | 94086 |
(Address of principal executive offices) | (Zip Code) |
|
|
Registrant’s telephone number, including area code: (408) 530-1900
No change
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD Disclosure.
On September 26, 2014, Viveve Medical, Inc. issued a press release announcing its new investor relations website. A copy of the press release is filed herewith as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
|
|
|
|
Exhibit No. | Description |
99.1 | Press Release dated September 26, 2014 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: September 26, 2014 |
|
|
| ||||
| VIVEVE MEDICAL, INC. |
| |||||
|
|
|
| ||||
|
|
|
| ||||
| By: | /s/ Patricia Scheller |
| ||||
|
| Patricia Scheller |
| ||||
|
| Chief Executive Officer |
| ||||
EXHIBIT INDEX
Exhibit No. | Description |
99.1 | Press Release dated September 26, 2014 |